Probe of Alibaba unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers — but DOJ did not prosecute
The scaled-backed Alibaba settlement reflects a broader trend by the DOJ of pulling back on criminal enforcement of corporate cases involving the safety of food, drugs, and medical devices.